Integra LifeSciences (IART) – StreetInsider.com Reports
-
Integra LifeSciences (IART) PT Lowered to $37 at Truist Securities
-
Citi Upgrades Integra LifeSciences (IART) to Neutral
-
Integra LifeSciences (IART) Completes Acquisition of Acclarent
-
Integra LifeSciences (IART) PT Lowered to $41 at Truist Securities, 'the company will need to demonstrate several quarters of execution'
-
Integra LifeSciences (IART) PT Lowered to $45 at Wells Fargo
-
Integra LifeSciences (IART) PT Lowered to $49 at JMP Securities
-
Integra LifeSciences (IART) Misses Q4 EPS by 1c, provides guidance
-
Integra LifeSciences (IART) Announces Resignation of Jan De Witte
-
Integra LifeSciences (IART) PT Raised to $46 at Truist Securities
-
Integra LifeSciences (IART) PT Raised to $44 at Truist Securities
-
Integra LifeSciences (IART) to Acquire Acclarent from Johnson & Johnson (JNJ) for $275M Cash
-
Integra LifeSciences (IART) Appoints Jeff Graves to its Board
-
Integra LifeSciences (IART) PT Raised to $38 at Citi
-
Wells Fargo Upgrades Integra LifeSciences (IART) to Overweight
-
CL King Starts Integra LifeSciences (IART) at Buy
-
Integra LifeSciences (IART) PT Lowered to $40 at BofA Securities
-
Integra LifeSciences (IART) PT Lowered to $37 at Morgan Stanley
-
Integra LifeSciences (IART) PT Lowered to $38 at JPMorgan
-
Integra LifeSciences (IART) PT Lowered to $40 at Wells Fargo
-
Integra LifeSciences (IART) PT Lowered to $55 at JMP Securities
-
Integra LifeSciences (IART) PT Lowered to $39 at Truist Securities
-
Integra LifeSciences (IART) Misses Q3 EPS by 2c; offers guidance
-
Integra LifeSciences (IART) PT Lowered to $41 at Truist Securities
-
Morgan Stanley Downgrades Integra LifeSciences (IART) to Underweight
-
Integra LifeSciences (IART) PT Raised to $44 at Morgan Stanley
-
Integra LifeSciences (IART) PT Lowered to $52 at Jefferies
-
Integra LifeSciences (IART) PT Lowered to $60 at JMP Securities
-
Integra LifeSciences (IART) Tops Q2 EPS by 14c
-
Integra LifeSciences (IART) PT Raised to $48 at Truist Securities
-
Jefferies Upgrades Integra LifeSciences (IART) to Buy, 'we view IART shares as oversold'
-
Integra LifeSciences (IART) Appoints Lea Daniels Knight as CFO
-
Argus Downgrades Integra LifeSciences (IART) to Hold
-
Integra LifeSciences (IART) PT Lowered to $43 at Morgan Stanley
-
Integra LifeSciences (IART) PT Lowered to $44 at Truist Securities
-
Kohl's, Urban Outfitters, Abercrombie&Fitch rise premarket; XPeng, Agilent fall
-
Integra LifeSciences (IART) PT Lowered to $47 at Wells Fargo
-
JPMorgan Downgrades Integra LifeSciences (IART) to Underweight
-
Integra LifeSciences (IART) plunges after product recall
-
Integra LifeSciences (IART) initiates voluntary global recall of all products manufactured at Boston facility
-
Citi Downgrades Integra LifeSciences (IART) to Sell, Sees Revenue Impact of $60M and EPS Impact of $0.35
-
Integra LifeSciences (IART) PT Lowered to $54 at Truist Securities
-
Integra LifeSciences (IART) PT Lowered to $65 at JMP Securities
-
Integra LifeSciences (IART) Reports In-Line Q1 EPS; revenue beat; offers guidance
-
Integra LifeSciences (IART) PT Raised to $62 at Truist Securities
-
InspireMD (NSPR) Appoints Andrea Tommasoli as COO
-
Integra LifeSciences (IART) PT Raised to $55 at Piper Sandler
-
Integra LifeSciences (IART) Files Mixed Shelf
-
Integra LifeSciences (IART) PT Raised to $60 at Jefferies
-
Integra LifeSciences (IART) Tops Q4 EPS by 4c; Offers FY23 Guidance
-
Integra LifeSciences (IART) Prelim. Q4 EPS Tops Consensus
Back to IART Stock Lookup